Sona Nanotech – Next generation gold nanorods

We produce high-quality gold nanorod products for diagnostic tests & medical treatment applications

Sona's unique gold nanorods will power the next generation of lateral flow diagnostics

THE SONA ADVANTAGE

SonaCast - our all new podcast - is out now!
Subscribe on your favourite podcast platform.

Lateral Flow Diagnostic Applications

Food & Beverage

Medical Diagnostics

Environmental Testing

Consumer Health & Pharmaceuticals

Drugs of Abuse

Military

Animal
Diagnostics

LATERAL FLOW TEST =
IMMEDIATE PATIENT FEEDBACK

Lateral flow tests powered by Sona’s unique gold nanorods can give results within minutes.

Sona’s multi-coloured gold nanorods allow for multiple test lines per unit, with easy-to-read results from one small sample.

Advantages of Sona's Nanorod Technology

Allows one test to detect multiple conditions
Allows one test to maximize use from a small sample
Allows one test to detect multiple analyses for specific conditions
Individual, distinct colours for quantification measurement
Generates amplified visual signals for simpler interpretation
Generates increased sensitivity, specificity & time to results
Sona nanorods have a longer shelf life and resistance to hot temperatures than current technology
Non toxic – CTAB free

Comprehensive suite of products and services for multiple applications

• Gold nanorods
• Custom conjugation
• Lateral flow test development
• Lateral flow test production

PRODUCTS & SERVICES

• Point of care diagnostics
• Drug delivery
• Photothermal therapy
• Cell imaging

APPLICATIONS

Praise for Sona's technology from businesses and academics

“I am very optimistic about the future of Sona; the gold nanorods they make are very versatile, with huge application potential in various fields.”

Dr Shine Xu Zhang

Industrial research chair in applied nanotechnology, Cape Breton University

“Gold nanorods that have been synthesized and stabilized without CTAB are obviously a safer alternative. The fact that such a particle is commercially available today is astonishing. This could be a very important step forward for a number of promising clinical methods.”

Dr Catherine J. Murphy

Gold nanorod pioneer, professor of chemistry, Department of Chemistry, University of Illinois

“Sona’s unique gold nanotechnology is very impressive and has the potential to transform lateral flow. We are proud to partner with such an innovative company and we know that together Sona and Bond can achieve great things.”

Phil Groom

Commercial Director, Bond Digital Health

Upcoming events

Meet members of Team Sona and learn more about our technology, products and services at these upcoming events:

• Advanced Lateral Flow Course, 22-24 October 2019, San Diego, CA, USA

To arrange a meeting or learn more, get in touch.

Latest News

Sona Nanotech Inc. and Expedeon AG Strengthen Partnership to Improve Global Market Offering

Diagnostics companies sign new commercial agreement to address limitations in development of multiplex point-of-care lateral flow assay diagnostic tests Halifax, Nova Scotia–(Newsfile Corp. – August 6, 2019) – Sona Nanotech Inc. (CSE: SONA) and Expedeon AG (FSE: EXN) (ISIN: DE000A1RFM03), today announced they have entered into a commercial agreement to address limitations in development of complex, multiplex point-of-care (POC) lateral flow assay (LFA) diagnostic tests. Under the terms of the agreement, Expedeon will provide gold nanoparticle, bioconjugation technologies and expertise, and Sona will offer its lateral flow assay development services, leading to immediate and ongoing revenue generation. The collaboration will

August 6, 2019

SONA NEWS

Latest Blog Post

Why Sona Nanotech’s unique gold nanorods have strong potential in next generation diagnostics and cancer treatment

Sona CEO Darren Rowles and Prof. Zoe Pikramenou at the University of Birmingham Over the last year, a joint project between the University of Birmingham and Sona Nanotech Inc. has been developing next-generation gold nanorods for tissue imaging. The ultimate aim of the project, led by Zoe Pikramenou, Professor of Inorganic Chemistry and Photophysics at the University of Birmingham, is to investigate whether gold nanorods could be used to target cancer cells in the human body. Cancer is already one of the leading causes of death worldwide and it is expected that the number of new cases of cancer per

September 25, 2019

SONA BLOG

Subscribe to the Sona Newsletter